氯胺酮治疗抵抗性抑郁症：范围综述。
Ketamine for resistant depression: a scoping review.
机构信息
Medicine School, Universidad de La Sabana, Chía, Colombia.
Medicine School, Fundación Universitaria de Ciencias de la Salud, Bogotá, Colombia.
出版信息
Actas Esp Psiquiatr. 2022 May;50(3):144-159. Epub 2022 May 1.
Ketamine is a fast-acting anesthetic with hypnotic properties. Moreover, could potentially improve affective symptoms in patients with refractory depressive disorder. Objective. explore the scientific literature available until December 10, 2021, about the efficacy and safety of ketamine in patients with treatment-refractory major depressive disorder. Material and methods. Scoping review that included PubMed and Scopus. Records of clinical trials and publications with empirical data in English and Spanish were included.
氯胺酮是一种具有催眠作用的快速作用麻醉剂。此外，它可能会改善难治性抑郁症患者的情感症状。目的。截至 2021 年 12 月 10 日，探索关于氯胺酮治疗难治性重度抑郁症患者的疗效和安全性的现有科学文献。材料和方法。包括 PubMed 和 Scopus 的范围综述。纳入了临床试验记录和具有英语和西班牙语实证数据的出版物。
Zotero 插件